Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00830232 · ClinicalTrials.gov registry record · NA

Effects of Carotid Stent Design on Cerebral Embolization

A NA study, sponsored by Dallas VA Medical Center.

Completed
Registry status
NA
Development phase
40
Enrollment target

NCT00830232: Completed NA study, sponsored by Dallas VA Medical Center.

NCT00830232 is a NA study that has completed, run by Dallas VA Medical Center. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00830232, a NA study, has completed, sponsored by Dallas VA Medical Center.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target

Study Summary

The goal of the proposed study is to contrast the relative efficacy of closed-cell stents versus open-cell stents in preventing periprocedural cerebral embolization in high-risk patients with symptomatic and asymptomatic extracranial carotid stenosis undergoing carotid artery stenting (CAS).

Primary Outcome

Bilateral transcranial Doppler scan monitoring of the anterior and middle cerebral arteries was performed using a PMD150-ST3 digital transcranial Doppler pulsed-wave ultrasound scan system (Spencer Technologies, Seattle, Wash) with 2-MHz probes located over the temporal bones above the zygomatic arch. Isolated microembolic signals (MES) were identified from Doppler spectras according to the criteria given by the Consensus Committee of the Ninth International Cerebral Hemodynamic Symposium. If th

Interventions

  • DEVICE closed-cell stent (Xact stent)
  • DEVICE Open-cell stent (Acculink carotid)

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2008-12
Est. Completion 2012-02
Phase NA
Dallas VA Medical Center

20 total trials

What the finished NCT00830232 record still lists

NCT00830232 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 2 interventions - of which closed-cell stent (Xact stent) is the first listed.

NCT00830232 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00830232 about?

NCT00830232 is a clinical study titled "Effects of Carotid Stent Design on Cerebral Embolization". The goal of the proposed study is to contrast the relative efficacy of closed-cell stents versus open-cell stents in preventing periprocedural cerebral embolization in high-risk patients with symptomatic and asymptomatic extracranial carotid stenosis undergoing carotid artery stenting (CAS).

What is the current status of trial NCT00830232?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2008-12. Estimated completion is 2012-02.

What interventions are being tested in trial NCT00830232?

The interventions under investigation include: closed-cell stent (Xact stent) (DEVICE), Open-cell stent (Acculink carotid) (DEVICE).

Who is sponsoring clinical trial NCT00830232?

This trial is sponsored by Dallas VA Medical Center, which has 20 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00830232's enrollment target sits among peer trials

40 1447th of 2000 higher than 465 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00830232, the US trial registry maintained by the National Library of Medicine. NCT00830232 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.